Welcome.
Are you a patient or carer?

This information is intended solely for patients who have been prescribed a Chiesi product by a UK healthcare professional, and their carers. Please confirm below, or go back to the home page.

UK-RES-2101605 August 2021
Last updated: 17th June 2021

Chiesi is experiencing an increase in inhaler demand. In order to help meet this increased demand of inhalers, we have decided to release a Clenil batch variation for all strengths.

  • The Clenil batch variation contains the same medication as before, and therefore requires no difference to how you manage your asthma.
  • The Clenil batch variation remains in the same type of inhaler device (pressurised metered dose inhaler; pMDI), and therefore requires no difference to the way you take your inhaler.
  • The only difference is that unlike Clenil inhalers that you may have received since September 2019, there is no dose indicator.

Please note: If you have been prescribed Clenil 100mcg, your inhaler may also have the following differences in appearance (see below):

  • The colours of the main body of the inhaler and mouthpiece protective cap are beige and yellow, respectively (instead of brown and beige, respectively).
  • You will not see 'Clenil® Modulite 100mcg Inhaler PREVENTER' embossed on the inhaler.
  • Clenil 100mcg inhaler batch-specific variation
  • Clenil 100mcg inhaler from a regular batch

You should check the dosage on the labelling of the outer package and canister of your Clenil inhaler prior to taking your inhaler to ensure that you have received the expected inhaler strength.

As usual, be sure to keep track of when you start to use your inhaler – each Clenil inhaler contains 200 doses of medication, so if you are taking two puffs of your inhaler twice a day, this means the inhaler will last for over a month.

If you use a Volumatic™ Spacer Device, you should continue to use it as usual.

Remember to clean your inhaler once a week. You will find instructions on how to do this on the package leaflet.

A downloadable version of this information is available here.

Reporting of side effects: If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.

UK-CLE-2100036 September 2021

You are now leaving Chiesi's website

By clicking this link, you will be taken to a website that is not owned or controlled by Chiesi. Chiesi is not responsible for the content provided on that site.

Continue
Go back

UK-RES-2101574 August 2021

Clenil® - Device Image

About Clenil®

Your doctor, nurse or pharmacist has prescribed a Clenil inhaler to help you to manage your asthma.

You can find out more about asthma by speaking to your doctor, nurse or pharmacist or by visiting Asthma UK. Taking your inhaler regularly can help to manage your symptoms.

Clenil® Modulite® pMDI Devices
Helpful resources
How to use your device - Play Button - Video: 5 minutes 13 seconds
Clenil User Guide - Download Button - PDF: 0.36mb
Patient Information Leaflets - Download Button - Available for: 50mcg, 100mcg, 200mcg & 250mcg
Play Button - How to use your device - Video: 5 minutes 13 seconds
Clenil User Guide - Download Button - PDF: 0.36mb
Download Button - Patient Information Leaflets - Available for: 50mcg, 100mcg, 200mcg & 250mcg

This website has been provided by Chiesi Limited to support patients, and carers of patients, prescribed Chiesi respiratory products. If you have not been prescribed Clenil and are looking for information on another Chiesi respiratory product please visit our homepage.

Reporting of side effects: If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.